• Australian (ASX) Stock Market Forum

Hello and welcome to Aussie Stock Forums!

To gain full access you must register. Registration is free and takes only a few seconds to complete.

Already a member? Log in here.

ARX - Aroa Biosurgery

Discussion in 'Stocks 0-H' started by System, Jul 10, 2020.

  1. System

    System Administrator

    Posts:
    2,960
    Likes Received:
    59
    Joined:
    Jun 27, 2010
    Aroa Biosurgery is a soft tissue regeneration company that commenced operations in 2008. Aroa focuses on improving the rate and quality of healing in complex wounds and soft tissue reconstruction.

    From over 10 years of research and development, Aroa has developed Endoform®, a proprietary soft tissue regeneration technology platform. Endoform® can temporarily replace damaged tissue by acting as a scaffold in the wound or the soft tissue to grow new tissue. It is used where tissue has been lost or damaged by disease or injury. Currently, Aroa has five commercial products based on the Endoform® technology, alongside a new product development pipeline.

    Aroa is based in Auckland, New Zealand, with an additional sales office and distribution function in the United States.

    It is anticipated that ARX will list on the ASX on 30 July 2020.

    https://aroabio.com
     
  2. Dona Ferentes

    Dona Ferentes

    Posts:
    1,828
    Likes Received:
    1,957
    Joined:
    Jan 11, 2016
    still on track for end July

    ..Aroa is raising $45m as part of the IPO & will list with an indicative market capitalisation of A$225m under the code ARX. Bell Potter and Wilsons are Joint Lead Managers to the IPO.
    ..
    Aroa’s products are covered by a patent portfolio that includes 10 patents and 25 pending patent applications across six patent families
    ..NZ$22m in product revenue FY20 (ending 31 March 2020) & EBITDA positive

    At listing Aroa Founder and CEO Brian Ward will have an 11% shareholding.
     
  3. Dona Ferentes

    Dona Ferentes

    Posts:
    1,828
    Likes Received:
    1,957
    Joined:
    Jan 11, 2016
    came on market Friday 25th. ....up 80%
    The $45 million raised from the listing will go towards financing Aroa's US expansion. With the Capital raise five times oversubscribed, no institution received a full allocation for what they applied.

    Institutional investors that bought into the IPO include Ellerston Capital, Washington H. Soul Pattinson, Firetrail Investments, Perennial Value Management, OC Funds and Regal Funds Management.

    Mr Ward retains the largest shareholding following the listing with 11 per cent of the business, while New Zealand venture capital fund Movac, Movac partners Phil McCaw (who is also a board member) and Richard Abbott, and the Aspire NZ Seed Fund make up the other top five shareholders.
    Long-time Aroa chairman Jim McLean said the overriding sentiment when the company listed on Friday was "justifiable satisfaction".
     
  4. Dona Ferentes

    Dona Ferentes

    Posts:
    1,828
    Likes Received:
    1,957
    Joined:
    Jan 11, 2016
    IPO @ 75c a share on Friday 24 July

    upload_2020-8-1_16-51-52.png
     
  5. Garpal Gumnut

    Garpal Gumnut

    Posts:
    9,696
    Likes Received:
    1,183
    Joined:
    Jan 2, 2006
    Thanks @Dona Ferentes

    This is on my watchlist to buy when the market crashes.

    gg
     
Loading...

Share This Page